Breaking News

Sulzer Confirms Merger Talks With Dresser-Rand
Tweet TWEET

CareFusion Provides Update on Form 10-K, 10-Q Filings

            CareFusion Provides Update on Form 10-K, 10-Q Filings

PR Newswire

SAN DIEGO, Dec. 19, 2012

SAN DIEGO, Dec. 19, 2012 /PRNewswire/ --CareFusion Corporation (NYSE: CFN)
said today it has completed the majority of the analysis to be used in
determining the impact of an accounting modification on its financial
statements. Based on the analysis to date, the company has not identified
information that would lead it to conclude that its previously issued
financial statements should no longer be relied upon. CareFusion is in the
process of completing its analysis and the documentation required to finalize
its fiscal 2012 independent audit.

As previously disclosed, CareFusion is modifying the manner in which it
applies lease accounting principles to sales-type leases in its Pyxis^®
medication and supply dispensing product lines, delaying the filing of its
Form 10-K for fiscal 2012 and Form 10-Q for the quarter ended Sept. 30.

The matter does not affect CareFusion customers or the underlying fundamentals
and cash flows of the company or its Pyxis business.

"While restatement will continue to be a possibility until our analysis is
complete, we have not identified any information that would lead us to
conclude that our previously issued financial statements should no longer be
relied upon or that the financial guidance we provided for fiscal 2013 should
be changed," said James F. Hinrichs, chief financial officer. "If at any time
we determine a material misstatement exists, we would file a Form 8-K shortly
thereafter announcing a restatement is required. At this point, our goal is to
become current in all filings by our next deadline on Feb. 11, 2013. Clearly,
we are working diligently to file sooner, if possible."

On Nov. 8, the company said it would provide an update on the matter in
approximately one month. As a result, CareFusion will host a webcast and
conference call today at 5 a.m. PST (8 a.m. EST). 

To access the call, visit the Investors page at www.carefusion.com. Log on at
least 15 minutes before the call begins to register and download or install
any necessary audio software. Investors and other interested parties may also
access the call by dialing (800) 510-0146 within the U.S. or (617) 614-3449
from outside the U.S., using the access code 64995265. A replay of the
conference call will be available from 7 a.m. PST (10 a.m. EST) on Dec. 19
through 11:59 p.m. PST on Dec. 26 (2:59 a.m. EST on Dec. 27) and can be
accessed by dialing (888) 286-8010 in the U.S. or (617) 801-6888
internationally and using the access code 67989805.

About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve the
safety and quality of care. The company develops market-leading technologies
including Alaris^® infusion pumps, Pyxis^® automated dispensing and patient
identification systems, AVEA^®, AirLife^™ and LTV^® series ventilation and
respiratory products, ChloraPrep^® skin prep products, MedMined^® services for
data mining surveillance, V. Mueller^® surgical instruments, and an extensive
line of products that support interventional medicine. CareFusion employs more
than 15,000 people across its global operations. More information may be found
at http://www.carefusion.com/.

Cautions Concerning Forward-looking Statements

The CareFusion news release and the information contained herein present
"forward-looking statements" addressing expectations, prospects, estimates and
other matters that are dependent upon future events or developments, including
statements regarding the modified application of lease accounting principles
to the company's sales-type leases; the analysis regarding the impact of the
accounting modification; the potential impact of the accounting modification
on the company's reported financial results and financial guidance; and the
timing for filing the company's Form 10-K for fiscal 2012 and Form 10-Q for
the quarter ended Sept. 30. CareFusion intends forward-looking terminology
such as "believes," "expects," "may," "will," "should," "anticipates,"
"plans," or similar expressions to identify forward-looking statements. Such
statements are subject to certain risks and uncertainties, which could cause
the company's actual results to differ materially from those anticipated by
the forward-looking statements. These risks and uncertainties include, but are
not limited to, the risk that additional information may arise during the
course of the company's lease accounting review that may require the company
to make additional adjustments; the time and effort required to complete the
company's analysis and the review by the company's independent auditors; and
the time and effort required to make any adjustments to the company's
financial reports, if required, as well as other risks described more fully in
Item 1A in the company's Annual Report on Form 10-K for the fiscal year ended
June 30, 2011, which are expressly incorporated herein by reference, and other
factors as may periodically be described in the company's filings with the
SEC. The CareFusion news release and the information contained herein reflect
management's views as of Dec. 19, 2012. Except to the limited extent required
by applicable law, CareFusion undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE CareFusion Corp.

Website: http://www.carefusion.com
Contact: Media: Kristen Cardillo, +1-858-617-2317,
kristen.cardillo@carefusion.com; Investors: Jim Mazzola, +1-858-617-1203,
jim.mazzola@carefusion.com
 
Press spacebar to pause and continue. Press esc to stop.